# ALX Oncology Holdings Inc: Form SC 13D/A, filed Dec 20, 2023

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: SC 13D/A
- Filed: 2023-12-20
- Accepted by EDGAR: Dec 19, 2023, 22:38 ET
- Period: not reported
- Accession: 0001104659-23-127396
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000110465923127396/tm2332991d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000110465923127396/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000110465923127396/tm2332991d1_sc13da.htm

Filed Dec 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-127396. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.